NeurosciencebioRxivPreprint
ARGX-119, a therapeutic agonist antibody targeting MuSK
Roeland Vanhauwaert, Julien Oury, Bernhardt Vankerckhoven…·Steven J. Burden
ARGX-119 is a novel first-in-class MuSK agonist monoclonal antibody in clinical development for treatment of neuromuscular diseases.
1 citation